Ionis Pharmaceuticals, Inc. Common Stock (IONS) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for IONS. 13F holdings as of 2026-09-30.

In 13F filings for the quarter ended September 30, 2026, 170 institutions reported holding IONS, with 80.1 million shares worth $3.6 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
FMR24,740,108$1.1BINCREASED
BlackRock13,192,834$589MINCREASED
Vanguard8,790,658$393MDECREASED
State Street5,710,900$255MINCREASED
Geode Capital Management3,277,569$146MDECREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Michael R Hayden (Director)BUY5,000$148K2026-11-10
Shannon L. Devers (EVP, Chief Human Resources Ofc)SELL1,357$59K2026-10-16
Eric Swayze (EVP Research)SELL53$2K2026-10-16
Shannon L. Devers (EVP, Chief Human Resources Ofc)EXERCISE2,8202026-10-15
Shannon L. Devers (EVP, Chief Human Resources Ofc)EXERCISE2,8202026-10-15

Full institutional holdings, insider history, and congressional trades for Ionis Pharmaceuticals, Inc. Common Stock on SentiSense.